Letter to the Editor Regarding ‘Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis’
Crossref DOI link: https://doi.org/10.1007/s13555-021-00503-1
Published Online: 2021-03-04
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luger, Thomas http://orcid.org/0000-0003-1397-1626
Ranjan, Sandip
Funding for this research was provided by:
Meda Pharma S.p.A., a Viatris company
Text and Data Mining valid from 2021-03-04
Version of Record valid from 2021-03-04
Article History
Received: 26 November 2020
First Online: 4 March 2021